Non-organ-specific autoantibodies in hepatitis C virus infection: Do they matter?

Clinical Infectious Diseases

Volumn 40, Issue 4, 2005, Pages 508-510

  Bogdanos, Dimitrios Petrou ^a   Mieli Vergani, Giorgina ^a   Vergani, Diego ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MITOCHONDRION ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; NON ORGAN SPECIFIC AUTOANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; CHRONIC DISEASE; EDITORIAL; ENZYME ACTIVITY; HEPATITIS C; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; ANTIBODY SPECIFICITY; ANTIVIRAL AGENTS; AUTOANTIBODIES; CHILD; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; RIBAVIRIN; TRANSAMINASES; TREATMENT OUTCOME;

EID: 13944262850     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427293     Document Type: Editorial

References (15)

1. Bogdanos DP, Mieli-Vergani G, Vergani D. Virus, liver and autoimmunity. Dig Liver Dis 2000; 32:440-6.
2. Bogdanos DP, Mieli-Vergani G, Vergani D. Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis 2004; 38:1505.
3. Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997; 26:561-6.
4. Gregorio GV, Pensati P, Iorio R, et al. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998; 112:471-6.
5. Lenzi M, Bellentani S, Saccoccio G, et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 1999;45:435-41.
6. Muratori P, Muratori L, Verucchi G, et al. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 2003; 37:1320-6.
7. Stroffolini T, Colloredo G, Gaeta GB, et al. Does an " autoimmune" profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 2004; 11: 257-62.
8. Wasmuth HE, Stolte C, Geier A, et al. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. BMC Infect Dis 2004; 4:4.
9. Bogdanos DP, McFarlane IG. Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol 2003; 39:860-3.
10. Vergani D, Alvarez F, Bianchi FB, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41:677-83.
11. Gregorio GV, Choudhuri K, Ma Y, et al. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol 2003; 133: 404-13.
12. Kerkar N, Choudhuri K, Ma Y, et al. Cytochrome P4502D6 (193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003; 170:1481-9.
13. Bogdanos DP, Lenzi M, Okamoto M, et al. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol 2004; 17: 83-92.
14. Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001; 21:225-32.
15. Muratori P, Muratori L, Guidi M, et al. Clinical impact of non-organ-specific autoantibodies (NOSAs) on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis 2005; 40:501-7 (in this issue).